Here, we demonstrated a novel mechanism by which TEM not only exhibits tumor-suppressive effects on breast cancer cells but also improves CD8+ T cell-mediated anti-cancer effects through the inhibition of breast cancer-derived sEV PD-L1 levels. The gene discussed is CD8A; the disease is breast cancer.